Differential Diagnosis - Pacific University

More documents

Recommendations

Info

5/29/2012 Orthokeratology Case Study: RF Topography Orthokeratology Case Study: RF CRT Dual Axis Lens Simulator Orthokeratology Case Study: RF CRT Dual Axis Lens Simulator Orthokeratology Case Study: RF CRT Dual Axis Lens Simulator Orthokeratology Case Study: RF CRT Dual Axis Lens Simulator Orthokeratology Case Study: RF Initial lens ordered and dispensed 9/2011: OD: Paragon CRT Dual Axis 8.9/550/600/35/11.0 OS: Paragon CRT Dual Axis 8.8/550/600/34/11.0 Slightly high riding lens Lens rest on lower lid due to tight lid architecture Expect improved centration with lid closure Dispensed for over-night wear Coursebook Page 49 of 139 4
5/29/2012 Orthokeratology Case Study: RF One-night follow-up the next morning Slightly high correction zone (smiley face) Uncorrected VA 20/50- OU Good corneal integrity Orthokeratology Case Study: RF One-night follow-up difference display Continue lens wear for one week Orthokeratology Case Study: RF One-week follow-up Slightly high correction zone Uncorrected VA 20/50- OU Good corneal integrity Topography shows residual myopia OU Adjust lens parameters to increase corneal flattening using simulator Orthokeratology Case Study: RF New Parameters ordered and dispensed 10/2011 OD: Paragon CRT Dual Axis 9.1/575/34/600/36/11.0 OS: Paragon CRT Dual Axis 9.0/575/34/600/36/11.0 Flattened Base Curve to increase central corneal flattening Adjusted individual axis to improve lens centration Flatten base curve to enhance central corneal flattening Steepen Landing Zone Angle at one meridian to match steeper vertical corneal meridian Orthokeratology Case Study: RF Follow-up with flatter base curve dual-axis lenses Central corneal staining with mild irritation and conj injection OD Uncorrected VA 20/25 OU Wider, slightly higher treatment area Axial difference display reveal residual myopia OS Orthokeratology Case Study: RF Discontinue lens wear Moxeza ophthalmic solution 1gtt bid x 5 days OD Nevanac ophthalmic suspension 1 gtt tid x 5 days OD Consider Multifocal SCL at follow-up Coursebook Page 50 of 139 5
Page 1 and 2: 2012 NORTHWEST RESIDENTS CONFERENCE
Page 3 and 4: 5/29/2012 Prevention, Diagnosis, an
Page 5 and 6: 5/29/2012 Other factors that resul
Page 7 and 8: 5/29/2012 For patients that qualif
Page 9 and 10: 5/29/2012 DMEK Better refractive pr
Page 11 and 12: 5/29/2012 A Case Presentation Case
Page 13 and 14: 5/29/2012 DFE: Periphery: Attache
Page 15 and 16: 5/29/2012 1)presumed HSV stromal ke
Page 17 and 18: 5/29/2012 Occurs mainly by 2 mechan
Page 19 and 20: 5/29/2012 3 Main Studies: 1. Acute
Page 21 and 22: 5/31/2012 Anna Griffith, O.D. Pacif
Page 23 and 24: 5/31/2012 Accommodative Therapy: Ne
Page 25 and 26: 5/31/2012 Vergence Progress Chart D
Page 27 and 28: 5/31/2012 BIVSS SYMPTOM CHECKLIST L
Page 29 and 30: 5/29/2012 Examination (11/14/2012)
Page 31 and 32: 5/29/2012 Origin Pathway http://rad
Page 33 and 34: 5/29/2012 11/30/2012 continued MRI
Page 35 and 36: 5/29/2012 03/14/2012 Lastly, addre
Page 37 and 38: 5/29/2012 Oliver Oliver Kuhn-Wilken
Page 39 and 40: 5/29/2012 The Inflammatory Cascade
Page 41 and 42: 5/29/2012 PGs and herpes simplex ke
Page 43 and 44: * Differential Diagnoses • Ankylo
Page 45 and 46: * Date Visual Acuity OD, OS IOP OD,
Page 47 and 48: 5/29/2012 Learning Objectives Case
Page 49: 5/29/2012 Orthokeratology Fitting
Page 53 and 54: 5/29/2012 Research Findings How Muc
Page 55 and 56: 5/29/2012 OVERVIEW ENDOTHELIAL CHAN
Page 57 and 58: 5/29/2012 SPECULAR MICROSCOPY APPLI
Page 59 and 60: 5/29/2012 RESEARCH STUDY SUMMARY C
Page 61 and 62: 5/29/2012 Impression 1 day follow u
Page 63 and 64: 5/29/2012 Management Management •
Page 65 and 66: 5/29/2012 Microbiology Microbiology
Page 67 and 68: 5/29/2012 Pertinent Findings Contd
Page 69 and 70: 5/29/2012 4 month post‐op (4/30/1
Page 71 and 72: 5/29/2012 Case Presentation • 83
Page 73 and 74: 5/29/2012 Histology Pathophysiology
Page 75 and 76: 5/29/2012 OUR CASE: OCT FINDINGS OD
Page 77 and 78: 5/29/2012 TAKE HOME POINTS Referenc
Page 79 and 80: 5/29/2012 Retina Evaluation… •
Page 81 and 82: 5/29/2012 Treatment • Intravitrea
Page 83 and 84: 5/29/2012 Baseline Exam Continued
Page 85 and 86: 5/29/2012 http://www.mrcophth.com/r
Page 87 and 88: 5/29/2012 Assessment/Plan: Assessm
Page 89 and 90: Objectives Perioperative Vision Los
Page 91 and 92: Case - Follow Up Case -Visual Field
Page 93 and 94: Coursebook Page 92 of 139
Page 95 and 96: 5/31/2012 What is Telemedicine Stor
Page 97 and 98: 5/31/2012 Co‐morbid Conditions
Page 99 and 100: 5/31/2012 Improved Compliance with
Page 101 and 102:
5/29/2012 Radioiodine Therapy and G
Page 103 and 104:
5/29/2012 06/27/11 WWVAMC 06/27/11
Page 105 and 106:
5/29/2012 Suspect Graves’ Ophthal
Page 107 and 108:
5/29/2012 10/12/11 • EOMS: smooth
Page 109 and 110:
5/29/2012 WWVAMC 11/21/11 - 1 month
Page 111 and 112:
5/29/2012 WWVAMC 12/19/11 - 2 month
Page 113 and 114:
5/29/2012 • VISUAL ACUITY: 04/12/
Page 115 and 116:
5/29/2012 04/12/12 Reduction in ede
Page 117 and 118:
5/29/2012 Graves’ Ophthalmopathy
Page 119 and 120:
5/29/2012 Prednisone Possible Drug
Page 121 and 122:
5/29/2012 Sources Sources • 1. Wa
Page 123 and 124:
5/29/2012 Gnathophyma Metophyma Oto
Page 125 and 126:
5/29/2012 CHEMICAL/FOOD EXPOSURE
Page 127 and 128:
5/29/2012 FEATURES OF OCULAR ROSACE
Page 129 and 130:
5/29/2012 FUNCTIONAL TREATMENT FOR
Page 131 and 132:
5/29/2012 TREATMENT • Pred Forte
Page 133 and 134:
5/29/2012 • C/D Ratio • OD: 0.4
Page 135 and 136:
5/29/2012 • Window defect associa
Page 137 and 138:
5/29/2012 • Cherry Red Spot • N
Page 139 and 140:
5/29/2012 • Ophthalmodynamometry
show all

Differential Diagnosis - Pacific University

Create successful ePaper yourself

Delete template?

Save as template?